Documentation requirements for overseas registration are a core topic for B.Pharm students involved in regulatory affairs and quality assurance. This brief guide outlines essential documents such as the Common Technical Document (CTD/eCTD) dossier, Certificate of Pharmaceutical Product (CPP), Good Manufacturing Practice (GMP) certificates, stability data, bioequivalence reports, Certificate of Analysis (CoA), manufacturing site master file, power of attorney, notarization/apostille and certified translations. It also covers labeling, patient information leaflets, pharmacovigilance plans and regulatory authority expectations including ICH stability zones and dossier legalisation. Mastery of these documents supports successful foreign marketing authorization and compliance. Now let’s test your knowledge with 30 MCQs on this topic.
Q1. Which module of the CTD primarily contains finished pharmaceutical product quality information including specifications and batch release data?
- Module 1 — Administrative Information
- Module 3 — Quality (Chemistry, Manufacturing and Controls)
- Module 4 — Nonclinical Study Reports
- Module 5 — Clinical Study Reports
Correct Answer: Module 3 — Quality (Chemistry, Manufacturing and Controls)
Q2. What is the primary purpose of a Certificate of Pharmaceutical Product (CPP) in overseas registration?
- To certify the bioequivalence of a generic product
- To confirm product licensing and regulatory status in the exporting country
- To list excipient suppliers and specifications
- To provide detailed clinical trial data
Correct Answer: To confirm product licensing and regulatory status in the exporting country
Q3. Which document demonstrates that a manufacturing site complies with Good Manufacturing Practice following an inspection?
- Certificate of Analysis (CoA)
- Good Manufacturing Practice (GMP) certificate
- Stability protocol
- Marketing authorization letter
Correct Answer: Good Manufacturing Practice (GMP) certificate
Q4. For stability dossiers, which guideline’s climatic zones are commonly referenced when planning stability studies for international registration?
- WHO technical report only
- ICH stability zones (Zones I–IV)
- FDA thermal classes
- ISO transportation classes
Correct Answer: ICH stability zones (Zones I–IV)
Q5. Which report is essential to demonstrate bioavailability equivalence for generic immediate-release oral solid dosage forms?
- Stability report
- Bioequivalence study report
- Pharmacovigilance plan
- Manufacturing site master file
Correct Answer: Bioequivalence study report
Q6. What is included in a Certificate of Analysis (CoA)?
- Detailed clinical study protocols
- Analytical test results and conformity to specification for a batch
- Marketing authorization renewal schedule
- List of all regulatory authorities notified
Correct Answer: Analytical test results and conformity to specification for a batch
Q7. Which document usually requires legalization or apostille for overseas regulatory submission?
- Analytical method validation report
- Power of attorney and GMP certificates
- Internal quality training records
- In-house standard operating procedures (SOPs) not intended for regulators
Correct Answer: Power of attorney and GMP certificates
Q8. Why are certified translations required for dossier documents?
- To change the technical content of the report
- To ensure regulators understand document content in their official language
- To hide proprietary manufacturing details
- To replace originals with translated versions permanently
Correct Answer: To ensure regulators understand document content in their official language
Q9. What does a manufacturing site master file (MSMF) typically describe?
- Clinical trial patient recruitment strategies
- Detailed site operations, facilities, equipment, and quality systems
- Advertising and promotional plans
- Sales forecasts and distribution channels
Correct Answer: Detailed site operations, facilities, equipment, and quality systems
Q10. Which dossier format is internationally preferred and structured into five modules for registration submissions?
- eCTD/CTD (Common Technical Document)
- Dossier-A (local country format)
- JSON regulatory package
- Summary of Product Characteristics (SmPC)
Correct Answer: eCTD/CTD (Common Technical Document)
Q11. What is the main role of a power of attorney in overseas drug registration?
- To authorize an agent to act on behalf of the manufacturer for submissions
- To provide clinical data summaries
- To certify analytical methods
- To register trademarks
Correct Answer: To authorize an agent to act on behalf of the manufacturer for submissions
Q12. Which document establishes the finished product’s approved labeling and patient information required for submission?
- Certificate of Analysis
- Summary of Product Characteristics (SmPC) / Prescribing Information and Patient Information Leaflet
- Manufacturing batch record
- Stability protocol
Correct Answer: Summary of Product Characteristics (SmPC) / Prescribing Information and Patient Information Leaflet
Q13. For a generic product registration, which document often replaces full clinical data?
- Long-term stability data
- Bioequivalence study report
- Marketing authorization in any country
- Sales and distribution agreements
Correct Answer: Bioequivalence study report
Q14. Which regulatory document outlines the minimum pharmacovigilance system requirements for a marketing authorization holder?
- Pharmacovigilance System Master File (PSMF)
- Stability protocol
- Batch manufacturing record
- Certificate of Analysis
Correct Answer: Pharmacovigilance System Master File (PSMF)
Q15. What information does an analytical method validation report provide?
- Clinical endpoints used in trials
- Evidence the analytical method is suitable, including accuracy, precision, specificity and robustness
- Marketing and pricing strategy
- Manufacturing site floor plans only
Correct Answer: Evidence the analytical method is suitable, including accuracy, precision, specificity and robustness
Q16. Which document demonstrates freedom to sell the product in the exporting country and is sometimes requested by importing regulators?
- Certificate of Pharmaceutical Product (CPP) / Certificate of Free Sale
- Bioequivalence certificate
- Analytical method validation
- Pharmacovigilance literature review
Correct Answer: Certificate of Pharmaceutical Product (CPP) / Certificate of Free Sale
Q17. When registering a product abroad, why is inclusion of the API manufacturer’s CoA important?
- It lists the clinical results of the drug
- It proves API quality, identity, purity and compliance with specifications
- It replaces the need for finished product testing
- It contains market forecasts
Correct Answer: It proves API quality, identity, purity and compliance with specifications
Q18. What is the usual minimum real-time stability data duration required to propose a tentative shelf-life at submission for many regulators?
- One month only
- Three months (accelerated only)
- Six months or more, depending on guidelines
- No data — shelf-life is assigned by the importer
Correct Answer: Six months or more, depending on guidelines
Q19. Which of these is a common requirement for document presentation in many countries?
- All documents must be submitted in the original language only
- Key documents must be translated into the official language and sometimes certified
- Handwritten documents are preferred over typed ones
- Only summaries are accepted; full reports are not required
Correct Answer: Key documents must be translated into the official language and sometimes certified
Q20. What is the purpose of providing batch release samples to an importing authority during registration?
- To distribute to local pharmacies immediately
- For analytical verification and to confirm manufacturing consistency
- To replace dossier documents
- To serve as advertising materials
Correct Answer: For analytical verification and to confirm manufacturing consistency
Q21. Which document contains the list of excipients, their functions and any safety information required for registration?
- Clinical study report
- Formulation and qualitative/quantitative composition section in Module 3
- GMP certificate
- Pharmacovigilance signal report
Correct Answer: Formulation and qualitative/quantitative composition section in Module 3
Q22. In eCTD submissions, what is an advantage over paper CTD?
- Requires more physical storage space
- Allows structured electronic navigation, lifecycle management, and faster review
- Eliminates need for translations
- Removes the need for signatures on any documents
Correct Answer: Allows structured electronic navigation, lifecycle management, and faster review
Q23. Which action is typically required if the GMP certificate is issued in a language different from the regulator’s official language?
- Submit without translation
- Provide a certified translation and possibly notarization/apostille
- Rewrite the certificate content as a summary
- Replace it with a CoA
Correct Answer: Provide a certified translation and possibly notarization/apostille
Q24. For biologic products, which additional dossier component is especially critical compared to small molecules?
- Standard excipient listing only
- Comprehensive manufacturing process, cell line information and characterization data
- Only stability data is required
- Marketing materials
Correct Answer: Comprehensive manufacturing process, cell line information and characterization data
Q25. What is a common regulator expectation regarding sample retention at the manufacturer?
- No retention is necessary after release
- Reserve retained samples for a defined period to allow retesting or dispute resolution
- Samples should be discarded immediately
- Only retain clinical trial samples, not commercial batches
Correct Answer: Reserve retained samples for a defined period to allow retesting or dispute resolution
Q26. Which document often contains the product’s approved therapeutic claims and prescribing information for assessment?
- Manufacturing batch record
- Summary of Product Characteristics (SmPC) / Product label
- Analytical method validation report
- GMP inspection checklist
Correct Answer: Summary of Product Characteristics (SmPC) / Product label
Q27. What should a registrar check when submitting a marketing authorization application to a country with strict local representation laws?
- That the sample size is large enough
- That a legally appointed local agent or authorized representative is included with appropriate power of attorney
- That manufacturing equipment photos are included only
- That the product price is disclosed
Correct Answer: That a legally appointed local agent or authorized representative is included with appropriate power of attorney
Q28. When might an importing regulator request a GMP inspection report in addition to a GMP certificate?
- When the product is non-sterile only
- When detailed inspection history or recent onsite inspection findings are needed to verify compliance
- When the product has a long shelf-life
- When only clinical data are submitted
Correct Answer: When detailed inspection history or recent onsite inspection findings are needed to verify compliance
Q29. Which document supports that the manufacturer has a functioning quality system for pharmacovigilance activities?
- Stability report
- Pharmacovigilance System Master File (PSMF) and local PV contact details
- Certificate of Analysis for each batch
- Facility floor plans
Correct Answer: Pharmacovigilance System Master File (PSMF) and local PV contact details
Q30. What is a typical regulatory expectation for the evidence of product purity related to impurities and degradation products?
- Only a single lot analysis is sufficient
- Validated analytical methods, impurity profiling, limits and batch data across batches
- Only visual inspection reports
- Marketing authorization in another country without data
Correct Answer: Validated analytical methods, impurity profiling, limits and batch data across batches
